Rocket Pharmaceuticals, Inc. Unrealized Gain (Loss) on Investments
Rocket Pharmaceuticals, Inc. (RCKT) reported Unrealized Gain (Loss) on Investments of -$100.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:UnrealizedGainLossOnInvestments · last filed 2026-08-10
- Rocket Pharmaceuticals, Inc. unrealized gain (loss) on investments for the quarter ending 2026-06-30 was $0.00.
- Rocket Pharmaceuticals, Inc. unrealized gain (loss) on investments for the quarter ending 2026-03-31 was -$100.00K.
- Rocket Pharmaceuticals, Inc. unrealized gain (loss) on investments for the quarter ending 2025-12-31 was -$22.00K.
- Rocket Pharmaceuticals, Inc. unrealized gain (loss) on investments for the quarter ending 2025-09-30 was -$100.00K, a 125.00% decline year-over-year.
- Rocket Pharmaceuticals, Inc. unrealized gain (loss) on investments for fiscal 2025 was -$97.00K.
- Rocket Pharmaceuticals, Inc. unrealized gain (loss) on investments for fiscal 2024 was -$253.00K, a 137.43% decline from fiscal 2023.
- Rocket Pharmaceuticals, Inc. unrealized gain (loss) on investments for fiscal 2023 was $676.00K.
- Rocket Pharmaceuticals, Inc. unrealized gain (loss) on investments for fiscal 2022 was -$196.00K.
| Period end | Unrealized Gain (Loss) on Investments 3 month | Unrealized Gain (Loss) on Investments 3 month as first filed | Unrealized Gain (Loss) on Investments 6 month | Unrealized Gain (Loss) on Investments 6 month as first filed | Unrealized Gain (Loss) on Investments 9 month | Unrealized Gain (Loss) on Investments 9 month as first filed | Unrealized Gain (Loss) on Investments 12 month | Unrealized Gain (Loss) on Investments 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$100.00K 10-Q · filed 2026-08-10 | -$122.00K derived: sum of 3 quarters · filed 2026-08-10 | -$222.00K derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2026-03-31 | -$100.00K 10-Q · filed 2026-05-07 | -$122.00K derived: sum of 2 quarters · filed 2026-05-07 | -$222.00K derived: sum of 3 quarters · filed 2026-05-07 | -$322.00K derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-12-31 | -$22.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$122.00K derived: sum of 2 quarters · filed 2026-02-26 | -$222.00K derived: sum of 3 quarters · filed 2026-08-10 | -$97.00K 10-K · filed 2026-02-26 | ||||
| 2025-09-30 | -$100.00K 10-Q · filed 2025-11-06 | -$200.00K derived: sum of 2 quarters · filed 2026-08-10 | -$75.00K 10-Q · filed 2025-11-06 | -$447.00K derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-06-30 | -$100.00K 10-Q · filed 2026-08-10 | -$200.00K 10-Q · filed 2026-08-10 | -$173.00K 10-Q · filed 2025-08-07 | -$347.00K derived: sum of 3 quarters · filed 2026-08-10 | $53.00K derived: sum of 4 quarters · filed 2026-08-10 | |||
| 2025-03-31 | -$100.00K 10-Q · filed 2026-05-07 | -$93.00K 10-Q · filed 2025-05-08 | -$247.00K derived: sum of 2 quarters · filed 2026-05-07 | $153.00K derived: sum of 3 quarters · filed 2026-05-07 | $53.00K derived: sum of 4 quarters · filed 2026-05-07 | |||
| 2024-12-31 | -$147.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $253.00K derived: sum of 2 quarters · filed 2026-02-26 | $153.00K derived: sum of 3 quarters · filed 2026-02-26 | -$253.00K 10-K · filed 2026-02-26 | ||||
| 2024-09-30 | $400.00K 10-Q · filed 2025-11-06 | $300.00K derived: sum of 2 quarters · filed 2025-11-06 | -$106.00K 10-Q · filed 2025-11-06 | $673.00K derived: sum of 4 quarters · filed 2025-11-06 | ||||
| 2024-06-30 | -$100.00K 10-Q · filed 2025-08-07 | -$537.00K 10-Q · filed 2025-08-07 | $273.00K derived: sum of 3 quarters · filed 2025-08-07 | $473.00K derived: sum of 4 quarters · filed 2025-08-07 | ||||
| 2024-03-31 | -$454.00K 10-Q · filed 2025-05-08 | $373.00K derived: sum of 2 quarters · filed 2025-05-08 | $573.00K derived: sum of 3 quarters · filed 2025-05-08 | -$27.00K derived: sum of 4 quarters · filed 2025-05-08 | ||||
| 2023-12-31 | $827.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $1.03M derived: sum of 2 quarters · filed 2025-02-27 | $427.00K derived: sum of 3 quarters · filed 2025-02-27 | $676.00K 10-K · filed 2025-02-27 | ||||
| 2023-09-30 | $200.00K 10-Q · filed 2024-11-07 | -$400.00K derived: sum of 2 quarters · filed 2024-11-07 | -$151.00K 10-Q · filed 2024-11-07 | $106.00K derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2023-06-30 | -$600.00K 10-Q · filed 2024-08-06 | -$365.00K 10-Q · filed 2024-08-06 | -$94.00K derived: sum of 3 quarters · filed 2025-02-27 | $106.00K derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2023-03-31 | $267.00K 10-Q · filed 2024-05-07 | $506.00K derived: sum of 2 quarters · filed 2025-02-27 | $706.00K derived: sum of 3 quarters · filed 2025-02-27 | $606.00K derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2022-12-31 | $239.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $439.00K derived: sum of 2 quarters · filed 2025-02-27 | $339.00K derived: sum of 3 quarters · filed 2025-02-27 | -$196.00K 10-K · filed 2025-02-27 | $196.00K 10-K · filed 2023-02-28 | |||
| 2022-09-30 | $200.00K 10-Q · filed 2023-11-07 | $100.00K derived: sum of 2 quarters · filed 2023-11-07 | -$435.00K 10-Q · filed 2023-11-07 | -$432.00K derived: sum of 4 quarters · filed 2024-02-27 | ||||
| 2022-06-30 | -$100.00K 10-Q · filed 2023-08-09 | -$604.00K 10-Q · filed 2023-08-09 | -$632.00K derived: sum of 3 quarters · filed 2024-02-27 | -$648.00K derived: sum of 4 quarters · filed 2024-02-27 | ||||
| 2022-03-31 | -$468.00K 10-Q · filed 2023-05-05 | -$532.00K derived: sum of 2 quarters · filed 2024-02-27 | -$548.00K derived: sum of 3 quarters · filed 2024-02-27 | -$554.00K derived: sum of 4 quarters · filed 2024-02-27 | ||||
| 2021-12-31 | -$64.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | -$80.00K derived: sum of 2 quarters · filed 2024-02-27 | -$86.00K derived: sum of 3 quarters · filed 2024-02-27 | -$119.00K 10-K · filed 2024-02-27 | ||||
| 2021-09-30 | -$16.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | -$22.00K derived: sum of 2 quarters · filed 2022-11-04 | -$55.00K 10-Q · filed 2022-11-04 | -$42.00K derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-06-30 | -$6.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$39.00K 10-Q · filed 2022-08-09 | -$26.00K derived: sum of 3 quarters · filed 2023-02-28 | -$186.00K derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-03-31 | -$33.00K 10-Q · filed 2022-05-06 | -$20.00K derived: sum of 2 quarters · filed 2023-02-28 | -$180.00K derived: sum of 3 quarters · filed 2023-02-28 | $124.00K derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2020-12-31 | $13.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$147.00K derived: sum of 2 quarters · filed 2023-02-28 | $157.00K derived: sum of 3 quarters · filed 2023-02-28 | $62.00K 10-K · filed 2023-02-28 | -$62.00K 10-K · filed 2021-03-01 | |||
| 2020-09-30 | -$160.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | $144.00K derived: sum of 2 quarters · filed 2021-11-05 | $49.00K 10-Q · filed 2021-11-05 | -$48.00K derived: sum of 4 quarters · filed 2022-02-28 | ||||
| 2020-06-30 | $304.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $209.00K 10-Q · filed 2021-08-09 | $112.00K derived: sum of 3 quarters · filed 2022-02-28 | $85.00K derived: sum of 4 quarters · filed 2022-02-28 | ||||
| 2020-03-31 | -$95.00K 10-Q · filed 2021-05-10 | -$192.00K derived: sum of 2 quarters · filed 2022-02-28 | -$219.00K derived: sum of 3 quarters · filed 2022-02-28 | $14.00K derived: sum of 4 quarters · filed 2022-02-28 | ||||
| 2019-12-31 | -$97.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | -$124.00K derived: sum of 2 quarters · filed 2022-02-28 | $109.00K derived: sum of 3 quarters · filed 2022-02-28 | $147.00K 10-K · filed 2022-02-28 | ||||
| 2019-09-30 | -$27.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $206.00K derived: sum of 2 quarters · filed 2020-11-06 | $244.00K 10-Q · filed 2020-11-06 | $324.00K derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2019-06-30 | $233.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $271.00K 10-Q · filed 2020-08-05 | $351.00K derived: sum of 3 quarters · filed 2021-03-01 | $223.00K derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2019-03-31 | $38.00K 10-Q · filed 2020-05-08 | $118.00K derived: sum of 2 quarters · filed 2021-03-01 | -$10.00K derived: sum of 3 quarters · filed 2021-03-01 | -$99.00K derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2018-12-31 | $80.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | -$48.00K derived: sum of 2 quarters · filed 2021-03-01 | -$137.00K derived: sum of 3 quarters · filed 2021-03-01 | -$127.00K 10-K · filed 2021-03-01 | $127.00K 10-K · filed 2019-03-08 | |||
| 2018-09-30 | -$128.00K 10-Q · filed 2018-11-09 | -$217.00K derived: sum of 2 quarters · filed 2018-11-09 | -$207.00K 10-Q · filed 2019-11-08 | -$217.00K derived: sum of 4 quarters · filed 2019-05-09 | ||||
| 2018-06-30 | -$89.00K 10-Q · filed 2018-08-14 | -$79.00K 10-Q · filed 2019-08-08 | -$89.00K derived: sum of 3 quarters · filed 2019-05-09 | -$89.00K derived: sum of 4 quarters · filed 2019-05-09 | ||||
| 2018-03-31 | $0.00 10-Q · filed 2019-05-09 | $10.00K 10-Q · filed 2018-05-11 | $0.00 derived: sum of 2 quarters · filed 2019-05-09 | $0.00 derived: sum of 3 quarters · filed 2019-05-09 | $0.00 derived: sum of 4 quarters · filed 2019-05-09 | |||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-08 | $0.00 derived: sum of 2 quarters · filed 2019-03-08 | $0.00 derived: sum of 3 quarters · filed 2019-03-08 | $0.00 10-K · filed 2019-03-08 | $38.00K 10-K · filed 2018-03-07 | |||
| 2017-09-30 | $0.00 10-Q · filed 2018-11-09 | $48.00K 10-Q · filed 2017-11-08 | $0.00 derived: sum of 2 quarters · filed 2018-11-09 | $0.00 10-Q · filed 2018-11-09 | $29.00K 10-Q · filed 2017-11-08 | -$13.00K derived: sum of 4 quarters · filed 2019-03-08 | ||
| 2017-06-30 | $0.00 10-Q · filed 2018-08-14 | $0.00 10-Q · filed 2018-08-14 | -$18.00K 10-Q · filed 2017-08-03 | -$13.00K derived: sum of 3 quarters · filed 2019-03-08 | -$28.00K derived: sum of 4 quarters · filed 2019-03-08 | |||
| 2017-03-31 | $0.00 10-Q · filed 2018-05-11 | -$18.00K 10-Q · filed 2017-05-10 | -$13.00K derived: sum of 2 quarters · filed 2019-03-08 | -$28.00K derived: sum of 3 quarters · filed 2019-03-08 | -$11.00K derived: sum of 4 quarters · filed 2019-03-08 | |||
| 2016-12-31 | -$13.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-08 | -$28.00K derived: sum of 2 quarters · filed 2019-03-08 | -$11.00K derived: sum of 3 quarters · filed 2019-03-08 | $0.00 10-K · filed 2019-03-08 | -$43.00K 10-K · filed 2017-03-16 | |||
| 2016-09-30 | -$15.00K 10-Q · filed 2017-11-08 | $2.00K derived: sum of 2 quarters · filed 2017-11-08 | $13.00K 10-Q · filed 2017-11-08 | $2.00K derived: sum of 4 quarters · filed 2017-11-08 | ||||
| 2016-06-30 | $17.00K 10-Q · filed 2017-08-03 | $28.00K 10-Q · filed 2017-08-03 | $17.00K derived: sum of 3 quarters · filed 2017-08-03 | $17.00K derived: sum of 4 quarters · filed 2017-08-03 | ||||
| 2016-03-31 | $11.00K 10-Q · filed 2017-05-10 | $0.00 derived: sum of 2 quarters · filed 2017-05-10 | $0.00 derived: sum of 3 quarters · filed 2017-05-10 | $0.00 derived: sum of 4 quarters · filed 2017-05-10 | ||||
| 2015-12-31 | -$11.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | -$11.00K derived: sum of 2 quarters · filed 2017-03-16 | -$11.00K derived: sum of 3 quarters · filed 2017-03-16 | -$11.00K 10-K · filed 2017-03-16 | $11.00K 10-K · filed 2016-03-23 | |||
| 2015-09-30 | $0.00 10-Q · filed 2016-11-09 | $0.00 derived: sum of 2 quarters · filed 2016-11-09 | $0.00 10-Q · filed 2016-11-09 | |||||
| 2015-06-30 | $0.00 10-Q · filed 2016-08-10 | $0.00 10-Q · filed 2016-08-10 | ||||||
| 2015-03-31 | $0.00 10-Q · filed 2016-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |